CareLit · DOI-Nachweis · Geburtshilfe und Frauenheilkunde
Comparative proteomic analysis of II trimester human amniotic fluid (AF) of normal and severe preeclampsia evolved pregnancies: identification of a new early marker of the pathology in a pilot study.
DOI 10.1055/s-2006-952301
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Fruscalzo, C Vascotto, AM Salzano, C D’Ambrosio, A Scaloni, C di Loreto, G Tell, D Marchesoni, F Quadrifoglio
ZeitschriftGeburtshilfe und Frauenheilkunde
Ausgabe09/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Preeclampsia is a life threatening disorder of pregnancy affecting about 2.5–3% of women and uterine artery Doppler ultrasound during the second trimester is nowadays the only useful screening test. Proteomic analysis allows to analyze the proteic profile of normal and affected subjects and to appreciate any difference in protein concentration or posttranslational modifications for new markers discover…
Zitieren
Zitierempfehlung
A Fruscalzo, C Vascotto, AM Salzano, C D’Ambrosio, A Scaloni, C di Loreto, G Tell, D Marchesoni, F Quadrifoglio (2006) Comparative proteomic analysis of II trimester human amniotic fluid (AF) of normal and severe preeclampsia evolved pregnancies: identification of a new early marker of the pathology in a pilot study. Geburtshilfe und Frauenheilkunde (09). https://doi.org/10.1055/s-2006-952301
Mit CareLit weiterarbeiten